KLRC1


Description

The KLRC1 (killer cell lectin like receptor C1) is a protein-coding gene located on chromosome 12.

KLRC1 is a gene that encodes a protein known as Killer cell lectin-like receptor C1. This protein is a type II transmembrane receptor that plays a crucial role in regulating immune responses.

KLRC1 is an immune inhibitory receptor that plays a critical role in self-nonself discrimination. It forms a complex with KLRD1 on cytotoxic and regulatory lymphocytes, recognizing the non-classical MHC class Ib molecule HLA-E loaded with self-peptides derived from the signal sequences of classical MHC class Ia molecules. This allows cytotoxic cells to monitor MHC class I expression in healthy cells and tolerate self. Upon binding HLA-E-peptide, KLRC1 transmits inhibitory signals through two ITIMs (immunoreceptor tyrosine-based inhibition motifs), recruiting INPP5D/SHP-1 and INPPL1/SHP-2 tyrosine phosphatases to oppose activating receptor signals. KLRC1 is a key inhibitory receptor on NK cells, regulating their activation and effector functions. It also counteracts T cell receptor signaling on memory/effector CD8-positive T cells, preventing autoimmunity. In intraepithelial CD8-positive gamma-delta regulatory T cells, KLRC1 triggers TGFB1 secretion, limiting cytotoxic programming of intraepithelial CD8-positive alpha-beta T cells and distinguishing harmless from pathogenic antigens. In HLA-E-rich tumor microenvironments, KLRC1 acts as an immune inhibitory checkpoint, potentially contributing to NK cell and tumor-specific T cell exhaustion.

KLRC1 is also known as CD159A, NKG2, NKG2A.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.